载脂蛋白 C 保护葡萄糖脑苷脂酶免受α-突触核蛋白的抑制。
Saposin C protects glucocerebrosidase against α-synuclein inhibition.
机构信息
Laboratory of Molecular Biophysics, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, and ‡Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health , Bethesda, Maryland 20892, United States.
出版信息
Biochemistry. 2013 Oct 15;52(41):7161-3. doi: 10.1021/bi401191v. Epub 2013 Oct 1.
Abstract
Mutations in GBA1, the gene for glucocerebrosidase (GCase), are genetic risk factors for Parkinson disease (PD). α-Synuclein (α-Syn), a protein implicated in PD, interacts with GCase and efficiently inhibits enzyme activity. GCase deficiency causes the lysosomal storage disorder Gaucher disease (GD). We show that saposin C (Sap C), a protein vital for GCase activity in vivo, protects GCase against α-syn inhibition. Using nuclear magnetic resonance spectroscopy, site-specific fluorescence, and Förster energy transfer probes, Sap C was observed to displace α-syn from GCase in solution and on lipid vesicles. Our results suggest that Sap C might play a crucial role in GD-related PD.
摘要
GBA1 基因突变是帕金森病（PD）的遗传风险因素。α-突触核蛋白（α-Syn）是 PD 中的一种蛋白，与 GCase 相互作用并能有效抑制酶活性。GCase 缺乏会导致溶酶体贮积症——戈谢病（GD）。我们发现，对于 GCase 在体内的活性非常重要的脑苷脂激活蛋白 C（Sap C）能够保护 GCase 免受 α-Syn 的抑制。利用核磁共振波谱、荧光定位和Förster 能量转移探针，我们发现 Sap C 可以在溶液中和脂质体上置换与 GCase 结合的 α-Syn。我们的结果提示 Sap C 可能在 GD 相关 PD 中发挥关键作用。
相似文献
1
Saposin C protects glucocerebrosidase against α-synuclein inhibition.载脂蛋白 C 保护葡萄糖脑苷脂酶免受α-突触核蛋白的抑制。
Biochemistry. 2013 Oct 15;52(41):7161-3. doi: 10.1021/bi401191v. Epub 2013 Oct 1.
2
Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C.葡萄糖脑苷脂酶二聚体在溶液中被其辅因子鞘脂激活蛋白C解离。
Biochem Biophys Res Commun. 2015 Feb 20;457(4):561-6. doi: 10.1016/j.bbrc.2015.01.024. Epub 2015 Jan 17.
3
Investigating the Impact of the Parkinson's-Associated GBA1 E326K Mutation on β-Glucocerebrosidase Dimerization and Interactome Dynamics Through an In Silico Approach.通过计算模拟方法探究帕金森病相关 GBA1 E326K 突变对β-葡萄糖脑苷脂酶二聚化及其互作组动态的影响。
Int J Mol Sci. 2024 Oct 24;25(21):11443. doi: 10.3390/ijms252111443.
4
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.α-突触核蛋白与葡萄糖脑苷脂酶相互作用，为帕金森病和戈谢病之间提供了一个分子联系。
J Biol Chem. 2011 Aug 12;286(32):28080-8. doi: 10.1074/jbc.M111.237859. Epub 2011 Jun 8.
5
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.载脂蛋白 C，溶酶体介导的α-突触核蛋白降解的关键调节因子。
Int J Mol Sci. 2022 Oct 9;23(19):12004. doi: 10.3390/ijms231912004.
6
Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.通过中子反射测量法和荧光光谱法探究膜结合型葡萄糖脑苷脂酶和α-突触核蛋白的结构特征。
J Biol Chem. 2015 Jan 9;290(2):744-54. doi: 10.1074/jbc.M114.610584. Epub 2014 Nov 26.
7
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.安布罗醇诱导缺陷型葡萄糖脑苷脂酶的恢复与 GBA1 突变型帕金森病细胞中 LIMP-2 和神经鞘脂激活蛋白 C 水平的升高有关。
Neurobiol Dis. 2015 Oct;82:235-242. doi: 10.1016/j.nbd.2015.06.008. Epub 2015 Jun 19.
8
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.溶酶体的功能与功能障碍：戈谢病及其与帕金森病关联的分子和细胞机制
Adv Drug Deliv Rev. 2022 Aug;187:114402. doi: 10.1016/j.addr.2022.114402. Epub 2022 Jun 25.
9
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.靶向 GBA1 通路以减缓帕金森病：临床方面、发病机制和新治疗途径的见解。
Pharmacol Ther. 2023 Jun;246:108419. doi: 10.1016/j.pharmthera.2023.108419. Epub 2023 Apr 19.
10
Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity.溶酶体神经酰胺调节组织蛋白酶 B 介导的神经节苷脂激活蛋白 C 和葡萄糖脑苷脂酶活性的加工。
Hum Mol Genet. 2022 Jul 21;31(14):2424-2437. doi: 10.1093/hmg/ddac047.
引用本文的文献
1
Prosaposin: A Multifaceted Protein Orchestrating Biological Processes and Diseases.鞘脂激活蛋白原：一种协调生物过程与疾病的多功能蛋白质。
Cells. 2025 Jul 22;14(15):1131. doi: 10.3390/cells14151131.
2
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.GBA1 相关帕金森病的临床、机制、生物标志物和治疗进展。
Transl Neurodegener. 2024 Sep 12;13(1):48. doi: 10.1186/s40035-024-00437-6.
3
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.帕金森病中α-突触核蛋白与膜的相互作用：机制和治疗策略。
Neurobiol Dis. 2024 Oct 15;201:106646. doi: 10.1016/j.nbd.2024.106646. Epub 2024 Aug 22.
4
Meta-analysis of the association of prosaposin polymorphisms rs4747203 and rs885828 with risk of Parkinson's disease.载脂蛋白前体基因多态性 rs4747203 和 rs885828 与帕金森病风险的关联的荟萃分析。
Acta Neurol Belg. 2024 Apr;124(2):573-580. doi: 10.1007/s13760-023-02446-0. Epub 2024 Jan 11.
5
Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance.α-突触核蛋白病中的基因突变-病理基础的分子机制及其临床意义。
Int J Mol Sci. 2023 Jan 20;24(3):2044. doi: 10.3390/ijms24032044.
6
The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.帕金森病相关 GBA 中自噬溶酶体系统 GBA 缺乏的后果。
Cells. 2023 Jan 3;12(1):191. doi: 10.3390/cells12010191.
7
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.载脂蛋白 C，溶酶体介导的α-突触核蛋白降解的关键调节因子。
Int J Mol Sci. 2022 Oct 9;23(19):12004. doi: 10.3390/ijms231912004.
8
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.分析外周血单个核细胞中 GBA 相关帕金森病的生化特征。
Mov Disord. 2021 May;36(5):1267-1272. doi: 10.1002/mds.28496. Epub 2021 Feb 22.
9
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.诊断神经病变型戈谢病：戈谢表型分类的新考虑因素和新挑战。
Mol Genet Metab. 2021 Feb;132(2):49-58. doi: 10.1016/j.ymgme.2021.01.002. Epub 2021 Jan 9.
10
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.GBA 突变、葡萄糖脑苷脂酶和α-突触核蛋白在 GBA 相关帕金森病中的相互作用及其靶向治疗方法：综述。
Transl Neurodegener. 2021 Jan 15;10(1):4. doi: 10.1186/s40035-020-00226-x.
本文引用的文献
1
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems.不同生产体系来源的重组β-葡糖苷脑苷脂酶的糖基化和功能。
Biosci Rep. 2013 Sep 25;33(5):e00071. doi: 10.1042/BSR20130081.
2
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.β-葡糖脑苷脂酶活性丧失并不影响神经元细胞中α-突触核蛋白的水平或溶酶体功能。
PLoS One. 2013 Apr 8;8(4):e60674. doi: 10.1371/journal.pone.0060674. Print 2013.
3
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity.膜结合的α-突触核蛋白与葡萄糖脑苷脂酶相互作用并抑制酶活性。
Mol Genet Metab. 2013 Jan;108(1):56-64. doi: 10.1016/j.ymgme.2012.11.010. Epub 2012 Nov 28.
4
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.葡萄糖脑苷脂酶抑制导致线粒体功能障碍和自由基损伤。
Neurochem Int. 2013 Jan;62(1):1-7. doi: 10.1016/j.neuint.2012.10.010. Epub 2012 Oct 23.
5
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.帕金森病脑黑质中葡萄糖脑苷脂酶缺乏。
Ann Neurol. 2012 Sep;72(3):455-63. doi: 10.1002/ana.23614.
6
The role of saposin C in Gaucher disease.载脂蛋白 C 在戈谢病中的作用。
Mol Genet Metab. 2012 Jul;106(3):257-63. doi: 10.1016/j.ymgme.2012.04.024. Epub 2012 May 5.
7
Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy.戈谢病由于脑苷脂激活蛋白 C 缺乏症引起，先前被描述为非神经病变型形式——米格列醇治疗 2 年后无明显效果。
Mol Genet Metab. 2011 Dec;104(4):627-30. doi: 10.1016/j.ymgme.2011.09.010. Epub 2011 Sep 16.
8
CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.CNS 表达的葡萄糖脑苷脂酶可纠正与 Gaucher 相关的突触核蛋白病小鼠模型中的α-突触核蛋白病理和记忆障碍。
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6. doi: 10.1073/pnas.1108197108. Epub 2011 Jul 5.
9
Exploring the link between glucocerebrosidase mutations and parkinsonism.探讨葡萄糖脑苷脂酶突变与帕金森病之间的联系。
Trends Mol Med. 2011 Sep;17(9):485-93. doi: 10.1016/j.molmed.2011.05.003. Epub 2011 Jul 1.
10
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.戈谢病葡萄糖脑苷脂酶和α-突触核蛋白在突触核蛋白病中形成一个双向致病环。
Cell. 2011 Jul 8;146(1):37-52. doi: 10.1016/j.cell.2011.06.001. Epub 2011 Jun 23.
Zotero 插件